Home/ Supplements/ Niacin/ Intensify Xtreme

Intensify Xtreme

product on market Capsule NDS Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 30% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The formula contains B vitamins, which are known to support energy metabolism and cellular function with strong research evidence. However, the specific components of the proprietary blend are not disclosed, resulting in limited evidence coverage for the overall profile. The product maintains a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Intensify Xtreme
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
30%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

10 mg (50% DV)
Within RDA (0.7× RDA) 196 studies (A:5, B:63)
5 mg (250% DV)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
100 mcg (1667% DV)
41.7× RDA — above typical dose 139 studies (A:1, B:44)
5 mg (50% DV)
Within RDA (1.0× RDA) 2 studies — no high-quality reviews
Intensify Xtreme Proprietary Blend
683 mg
Thermo-Lean Blend
Insul-Lean Blend
De-Fine Water Loss Blend
Thyro-Cut Complex
Thermo-Sorb Delivery Blend

Other Ingredients

Gelatin Microcrystalline Cellulose Magnesium Stearate FD&C Blue 1 FD&C Red 40 Titanium Dioxide
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

SUGGESTED USE FOR STACK: With 6-8 oz. of juice or water take 1 Intensify(R) XTREME capsule 30 minutes prior to your morning meal and 1 capsule 30 minutes prior to your afternoon meal.

Warnings & Precautions

WARNING: KEEP OUT OF REACH OF CHILDREN.

Do not use for more than 8 weeks.

Consult with your physician prior to use if you are taking medication, including but not limited to MAOI inhibitors, antidepressants, aspirin, blood thinning medications, nonsteroidal anti-inflammatory drugs or products containing phylephrine, ephedrine, pseudoepherine, or other stimulants.

Consult your physician prior to use if you have a medical condition, including but not limited to, heart, liver, kidney, or thyroid disease, psychiatric or epileptic disorders, difficulty urinating, diabetes, high or low blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Do not use if you are prone to dehydration or exposed to excessive heat. Discontinue use 2 weeks prior to surgery or if you experience rapid heartbeat, dizziness, severe headache or shortness of breath or upset stomach. Do not use if tamper evident seal is broken.

Intensity(R) XTREME and Censor(R) are not intended for use buy those under the age of 18.

Do not use this product if you are pregnant or nursing.

Do not use if allergic or contraindicated to aspirin.

Before consuming seek advice from a health care professional if you are unaware of your current health condition.

Do not consume synephrine or caffeine from other sources, including but not limited to, coffee, tea, soda, and other dietary supplements or medications containing phenylephrine or caffeine.

Do not exceed recommended dose.

Formulation Notes

Contains caffeine.

Includes: Raspberry Ketones Bacopa Monnieri Cinnulin PF(R)

Additional Information

STORE IN A COOL DRY PLACE. AVOID EXCESSIVE HEAT.

FAT BURNING STRONG THERMOGENIC DROP THE POUNDS!

To be used as part of a healthy lifestyle consisting of regular physical activity and a proper diet.

Support for: Energy/Focus/Fat Loss Diuretic/Appetite Control

MULTI-DIMENSIONAL WEIGHT LOSS HEALTHY WEIGHT LOSS KIT

INTENSIFY(R) Xtreme

Metadata

Product Details

DSLD Entry Date2014-04-25
Product TypeOther Combinations
FormCapsule
BrandNDS
DSLD ID32389
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.